Abstract: A method of treating infectious inflammation in a mammal, including man, which comprises administering to a mammal in need of such treatment, nitric oxide, in the form of gaseous nitric oxide or a nitric oxide donor, in combination with a glucocorticoid, said combination being used in a therapeutically effective amount to accomplish treatment of said inflammation. A pharmaceutical composition for treatment of such an inflammation.

Abstract: A method of treating infectious inflammation in a mammal, including man, which comprises administering to a mammal in need of such treatment, nitric oxide, in the form of gaseous nitric oxide or a nitric oxide donor, in combination with a glucocorticoid, said combination being used in a therapeutically effective amount to accomplish treatment of said inflammation. A pharmaceutical composition for treatment of such an inflammation.

Abstract: Use of inhalable gaseous nitric oxide (NO) in combination with a cyclooxygenase inhibitor for the manufacture of a medicament for treating pulmonary vasoconstriction or airway constriction in a mammal, including man, in order to counteract a hypo- or non-response to treatment with gaseous nitric oxide or nitric oxide donor only and/or to counteract a rebound response in the case of withdrawal of treatment with gaseous nitric oxide or nitric oxide donor only said combination being use in a therapeutically effective amount to accomplish relaxation of said pulmonary vasoconstriction or airway constriction. A method and a pharmaceutical preparation for the treatment of pulmonary vasoconstriction or airway constriction while using the above-mentioned combination.

Abstract: Nitric oxide or nitric oxide releasing or delivering compounds administered by the inhalation route to humans and animals in need thereof have a systemic and pulmonary effect of preventing or treating blood platelet aggregation and coagulation and thus, are useful for the prevention or treatment of systemic platelet aggregation, pulmonary emboli, angina pectoris and acute respiratory distress syndrome.

Abstract: An apparatus for controlling and dividing ventilation between lungs during their independent ventilation and connecting only one respirator with the lungs by means of a double-lumen bronchial tube. The apparatus comprises two parallel inspiratory paths and two parallel expiratory paths to separate gas flows between the respiratory and each of the lungs. Each path is connected to the double-lumen bronchial tube through inspiratory and expiratory branches respectively. One of the expiratory paths comprises a positive end-expiratory pressure valve to apply this pressure selectively, to one lung only. A threshold inspiratory valve is placed in one of the inspiratory paths having a common point with the expiratory path not containing the positive end-expiratory pressure valve. This threshold valve is connected in series with a pneumatic unidirectional valve and divides ventilation between the lungs and patterns optimal inspiratory flows.